OTCMKTS:IMRSQ - IMRIS Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseN/AToday's RangeN/A52-Week Range$0.0001 - $0.0040Volume500 shsAverage Volume500 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABeta-2.68 ProfileChartEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovascular markets. It also provides service and extended maintenance contracts, and accessories and disposables. The company was founded in 2005 and is based in Winnipeg, Canada. Receive IMRSQ News and Ratings via Email Sign-up to receive the latest news and ratings for IMRSQ and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:IMRSQ Previous SymbolNASDAQ:IMRS CUSIPN/A CIK1489161 Webhttp://www.imris.com/ Phone763-203-6300Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees121 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable IMRIS (OTCMKTS:IMRSQ) Frequently Asked Questions What is IMRIS's stock symbol? IMRIS trades on the OTCMKTS under the ticker symbol "IMRSQ." Has IMRIS been receiving favorable news coverage? Media coverage about IMRSQ stock has been trending neutral recently, InfoTrie Sentiment reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. IMRIS earned a media sentiment score of 0.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future. Who are some of IMRIS's key competitors? Some companies that are related to IMRIS include 21st North (ULGX), Nexeon Medsystems (NXNND), SONOVA HLDG AG/ADR (SONVY), SpectraScience (SCIE) and Vision Sciences (CGNT). What other stocks do shareholders of IMRIS own? Based on aggregate information from My MarketBeat watchlists, some companies that other IMRIS investors own include Albireo Pharma (ALBO), Theralase Technologies (TLT), Finisar (FNSR), Dextera Surgical (DXTR), Microbot Medical (MBOT), NeoGenomics (NEO), Mateon Therapeutics (MATN), SLS International (SLS), Scisys Group (SSY) and Acer Therapeutics (ACER). Who are IMRIS's key executives? IMRIS's management team includes the folowing people: Mr. Maurice L. Holloman, Exec. VP of Operations - Customer Support & Customer EngineeringMr. Andrew M. Flanagan, CEO & PresMr. Robert C. Korn, Sr. VP of Global Sales and Marketing (Age 54)Mr. Peter Simpson, Sr. VP of R&D How do I buy shares of IMRIS? Shares of IMRSQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is IMRIS's official website? The official website for IMRIS is http://www.imris.com/. How can I contact IMRIS? IMRIS's mailing address is 5101 SHADY OAK RD, MINNETONKA MN, 55343. The company can be reached via phone at 763-203-6300 or via email at [email protected] MarketBeat Community Rating for IMRIS (OTCMKTS IMRSQ)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 107 (Vote Outperform)Underperform Votes: 106 (Vote Underperform)Total Votes: 213MarketBeat's community ratings are surveys of what our community members think about IMRIS and other stocks. Vote "Outperform" if you believe IMRSQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMRSQ will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/24/2019 by MarketBeat.com StaffFeatured Article: Straddles Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.